Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03250078 · ClinicalTrials.gov registry record

A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals

A clinical trial of Pancreatic Neoplasms, sponsored by Nuvance Health.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT03250078 is a study of Pancreatic Neoplasms that is actively recruiting participants, run by Nuvance Health. The registered enrollment target is 200 participants, below the 595-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03250078, a study of Pancreatic Neoplasms, is actively recruiting participants, sponsored by Nuvance Health.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

The main goal of this study is to screen and detect pancreatic cancer and precursor lesions in individuals with a strong family history or genetic predisposition to pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for Pancreatic Cancer.

Conditions Studied

Pancreatic Neoplasms

Interventions

  • DIAGNOSTIC_TEST MRI/MRCP

Study Locations (1)

Connecticut

  • Nuvance Health - Norwalk

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2016-11
Est. Completion 2026-11

Sponsor

Nuvance Health

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03250078

The ClinicalTrials.gov registry entry for NCT03250078 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 595-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (66% lower). The listed sponsor is Nuvance Health, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreatic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which MRI/MRCP is the first listed.

NCT03250078 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03250078 about?

NCT03250078 is a clinical study titled "A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals". The main goal of this study is to screen and detect pancreatic cancer and precursor lesions in individuals with a strong family history or genetic predisposition to pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early sta...

What is the current status of trial NCT03250078?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2016-11. Estimated completion is 2026-11.

What conditions does trial NCT03250078 study?

This clinical trial studies the following conditions: Pancreatic Neoplasms.

What interventions are being tested in trial NCT03250078?

The interventions under investigation include: MRI/MRCP (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03250078?

This trial is sponsored by Nuvance Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03250078 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pancreatic Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pancreatic Neoplasms

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.